Lovaza

Lovaza Teaching 1948

SN instructed patient that lovaza is approved in the U.S. for treatment of patients with very high triglycerides (hypertriglyceridemia). Lovaza is indicated for: Hypertriglyceridemia, used as monotherapy , or in combination with a statin for patients with mixed dyslipidemia. Also as a secondary prevention after myocardial infarction. Infrequent side effects of lovaza: burping, indigestion, rash, taste problem. Rare side effects of Lovaza: blood clotting disorder. Life threatening allergic reaction, abnormal liver function tests, Itching.